Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PGNY
PGNY logo

PGNY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Progyny Inc (PGNY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
25.470
1 Day change
2.37%
52 Week Range
28.750
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

PGNY is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000. The stock has constructive analyst support and bullish options sentiment, but the current technical setup is only moderately positive, insider selling is notable, and the latest provided trend data suggests limited near-term upside after the recent move. Given the user wants a direct decision and is unwilling to wait for a better entry, my opinion is to hold rather than buy at the pre-market price of 24.7.

Technical Analysis

PGNY is in a short-term constructive but not decisive trend. MACD histogram is positive at 0.4, but it is contracting, which suggests momentum is fading. RSI_6 at 67.619 is near the upper neutral/borderline overbought area, so the stock is not cheap here. Moving averages are converging, indicating a possible transition phase rather than a strong breakout trend. Key levels: pivot 23.641, resistance 25.438 then 26.548, support 21.844 then 20.733. With pre-market price at 24.7, the stock is below first resistance but close enough that upside may be limited in the immediate term. Similar candlestick pattern data points to a possible +1.79% next day, but negative returns over the next week and month, which supports caution for a long-term entry today.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options positioning is strongly bullish, with very low put-call ratios and call-heavy activity. Open interest put-call ratio of 0.12 and option volume put-call ratio of 0.09 suggest traders are leaning decisively bullish. Call open interest is 4,733 versus put open interest of 575, and today’s option volume is far above the 30-day average. That said, the low IV percentile and rank imply the market is not pricing in a major catalyst surge, so sentiment is positive but not explosive.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
10

Positive Catalysts

  • ["Canaccord upgraded PGNY to Buy and raised target to $30, citing a more conservative guidance approach and expectations for revenue growth to reaccelerate later in 2026.", "Barclays raised its target to $27 and remains Overweight after better-than-expected utilization and positive early selling-season conversations.", "Citizens raised its target to $31 and highlighted Q1 revenue and EBITDA beats, strong balance sheet, and cash flow generation.", "BofA raised its target to $29 after a strong quarter and more stable utilization.", "Options sentiment is strongly bullish based on call dominance and low put-call ratios.", "No recent congress trading data and no politician/influential figure transactions were reported, so there is no negative event pressure from that angle."]

Neutral/Negative Catalysts

  • ["Insiders are selling, and selling increased 601.40% over the last month, which is a meaningful caution flag.", "Hedge funds are neutral, with no significant positive institutional accumulation trend over the last quarter.", "Technical momentum is only moderate, with contracting MACD and converging moving averages rather than a clean breakout.", "The stock-trend model suggests short-term upside may be limited after the next day, with negative expected performance over the next week and month.", "The financial snapshot data was unavailable, so there is no fresh confirmed quarter-by-quarter revenue and margin detail to strengthen the buy case."]

Financial Performance

The latest quarter financial snapshot was not provided due to an error, so a full financial assessment is limited. However, analyst commentary indicates Q1 revenue and adjusted EBITDA beat consensus, utilization was better than expected, and management’s guidance approach has been conservative enough to preserve a beat-and-raise pattern. Analysts also expect the company to lap unfavorable Amazon-related comparisons in the second half of 2026, which could help revenue growth reaccelerate. The latest referenced quarter is Q1 2026, and the tone around financial performance is positive.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is bullish and improving. Recent actions include Canaccord upgrading to Buy from Hold with a $30 target, Barclays raising target to $27 and staying Overweight, Citizens raising target to $31 and staying Outperform, and BofA raising target to $29 and keeping Buy. The main pros from Wall Street are improving utilization, conservative guidance that enables beats, strong balance sheet, cash flow generation, and potential for growth reacceleration later in 2026. The cons are lingering concerns about membership growth, labor-market sensitivity, and investor confidence rebuilding after prior volatility. Overall, Wall Street is net positive on PGNY, but the near-term setup is not strong enough to justify an immediate aggressive buy for this beginner long-term investor.

Wall Street analysts forecast PGNY stock price to rise
8 Analyst Rating
Wall Street analysts forecast PGNY stock price to rise
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 24.880
sliders
Low
26
Averages
29.75
High
34
Current: 24.880
sliders
Low
26
Averages
29.75
High
34
Canaccord
Hold
to
Buy
upgrade
$19 -> $30
AI Analysis
2026-05-19
Reason
Canaccord
Price Target
$19 -> $30
AI Analysis
2026-05-19
upgrade
Hold
to
Buy
Reason
Canaccord upgraded Progyny to Buy from Hold with a price target of $30, up from $19. The company's "more conservative guidance philosophy" over the last several quarters has reestablished a track record of beating quarterly estimates, the analyst tells investors in a research note. In addition, the firm says Progyny will begin to lap unfavorable compares from the transition of care agreement for departing Amazon members in the second half of 2026, likely driving its revenue growth back to double digits.
Barclays
Overweight
maintain
$23 -> $27
2026-05-18
Reason
Barclays
Price Target
$23 -> $27
2026-05-18
maintain
Overweight
Reason
Barclays raised the firm's price target on Progyny to $27 from $23 and keeps an Overweight rating on the shares post the earnings report. The company benefitted from better than expected utilization in the quarter, and management noted that early conversations from the current selling season have been positive, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PGNY
Unlock Now

People Also Watch